Debut and L’Oréal are developing more than 12 bioidentical, biobased alternatives to traditional cosmetic ingredients
California-based biotech company Debut is developing more than a dozen bioidentical, biobased ingredients to replace traditionally produced/sourced materials in L’Oréal skin, hair, makeup and fragrance products.
Previously, in June 2023, Debut completed a $34 million Series B financing round led by L’Oréal’s venture capital fund BOLD. Debut also launched its own internal proof-of-concept brand Deinde.
In the latest phase of the two companies’ collaboration, Debut will produce replacement ingredients through fermentation and cell-free technology. The project is in line with L’Oréal’s ambitious goal of using 95% biobased ingredients by 2030.
The collaboration comes at a time when the “clean alternative” trend in the beauty field is on the rise, which is said to replace traditional technologies with safer and more sustainable ingredients without negatively affecting efficacy.
"Making bioidentical ingredients at scale helps protect global biodiversity and ensures a responsible ingredient supply chain while continuing to prioritize quality and product performance," said Dr. Joshua Britton, Founder and CEO of Debut. "Debut is committed to creating bio-based formulations for all of its beauty products and has unparalleled capabilities in biotechnology, formulation and scale to catalyze this transformative shift in beauty."
"Our mission is to lead the biotech transformation. We capture value across the supply chain to ensure Debut's bioidentical and novel ingredients and products meet the huge global market demand for the next generation of sustainable beauty products. The beauty industry will be transformed to deliver lasting benefits to people and the planet."
"Through this exciting partnership and adoption of breakthrough technologies, we have the ability to drive the creation of more sustainable and effective products to meet consumer needs and meet our duty of care for the planet," said Guive Balooch, Global Managing Director of Enhanced Beauty and Open Innovation at L'Oréal. "This long-term agreement with Debut is another example of our commitment to an open innovation ecosystem and to shaping the future of beauty by working with best-in-class partners."
2026-09-01
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Kering and L'Oréal Form $4 Billion Strategic Alliance in Luxury Beauty and Wellness
-
L’Oréal Middle East Partners with BinSina Pharmacy to Promote Sustainable Beauty in the UAE
-
L’Oréal and Tru Diagnostic Collaborate on Epigenomic Research in Beauty and Personal Care
-
L’Oréal Opens New $160 Million R&D Center in New Jersey
-
L’Oréal and IBM Partner to Develop AI Models to Formulate More Sustainable Cosmetics
-
L’Oréal partners with Abolis Biotechnologies and Evonik to advance sustainable biobased beauty goals
-
H1 2024: L’Oréal stellar despite China blemishes
-
L’Oréal acquires 10% stake in Galderma
-
Galderma and L’Oréal enter into a scientific partnership
-
L’Oréal Paris Launches Hair Coloring Device
Recommend Reading
-
Lilly Bets US$3 Billion on China While Simultaneously Cracking Down on the Gray Market for Weight-Loss Drugs
-
BASF Raises BA and 2-EHA Prices as Acrylic Ester Costs Continue to Move Higher in Asia-Pacific
-
BorsodChem Raises MDI Prices by €500 as Cost Pressure in Europe’s Polyurethane Chain Continues to Escalate
-
EU Clears Bayer-KWS Sugar Beet Event
-
Lier Chemical Gains Momentum as Chlorantraniliprole Supply Stabilizes
-
EFSA Reviews Clodinafop Risk
-
Methanol Market Prices Show a Clear Upward Trend
-
MTBE Market Prices Surge and Then Fall
-
FDA Tightens the Solvent Side of Natural Color Production
-
March 12 Pure Benzene Market Price Rises